GlassScriptPhysician profile
Danielle Elisa Price
NPI 1750766796
$3,242.41
in general payments reported to CMS, 2019-2025
21 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $747 · 2022: $699 · 2023: $649 · 2024: $824 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,127.37 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $883.24 | 2021-2025 | Xtampza, Belbuca |
| Boston Scientific Corporation | $236.48 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $208.47 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Mallinckrodt Hospital Products INC. | $107.20 | 2021-2022 | |
| Valinor Pharma, LLC | $81.36 | 2023-2024 | Movantik |
| Virtus Pharmaceuticals LLC | $76.61 | 2021-2022 | |
| Stimwave Technologies Incorporated | $65.21 | 2021-2022 | |
| Redhill Biopharma INC. | $63.95 | 2021-2022 | |
| Si-Bone, INC. | $60.89 | 2024 | |
| Horizon Therapeutics Plc | $48.94 | 2021-2022 | |
| Averitas Pharma INC. | $48.04 | 2023 | Qutenza |
| Janssen Pharmaceuticals, INC | $43.45 | 2024 | Invega Sustenna |
| Protega Pharmaceutials INC | $37.18 | 2024 | Roxybond |
| Biodelivery Sciences International, INC. | $31.55 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $27.13 | 2025 | Reactiv8 |
| Convatec INC. | $26.12 | 2024 | |
| Lundbeck LLC | $22.90 | 2024 | Vyepti |
| Acelrx Pharmaceuticals, INC. | $19.66 | 2022 | |
| Amneal Pharmaceuticals LLC | $18.44 | 2023 | Lyvispah |
| Metacel Pharmaceuticals LLC | $8.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.